Below is a list of Apobiologix' marketed products.
This information is intended for residents of Canada only.
For more information about our products, visit
We are here for the long term, continuing our investment into a pipeline of biosimilars to ensure patients and HCPs have broad access to affordable medicines.
Apobiologix continues to invest in oncology biosimilars and expanding our portfolio to new therapeutic areas. Our focus remains on an unwavering commitment to transforming access in emerging biosimilar medicines - the same way we did in oncology.